Literature DB >> 60282

Immunological release of histamine from bovine leucocytes. Unusual adrenergic modulation.

M C Holroyde, P Eyre.   

Abstract

Sensitized bovine granulocytes release histamine when exposed to specific antigen. In comparison with in vitro systems in several other species, the modulation of this release by adrenergic agents is unique. Beta-Adrenoceptor stimulation potentiates (rather than inhibits), whereas alpha-adrenoceptor stimulation inhibits (rather than potentiates) histamine release. Adrenaline, which is generally considered to be a physiological antagonist of the anaphylactic reaction, potentiated histamine release in this study. Dopamine, which is present in high concentration in bovine mast cells, was without effect. The results are discussed in terms of the possible role of granulocytes in bovine hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60282      PMCID: PMC1445125     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  A method for the fluorometric assay of histamine in tissues.

Authors:  P A SHORE; A BURKHALTER; V H COHN
Journal:  J Pharmacol Exp Ther       Date:  1959-11       Impact factor: 4.030

2.  Leukocytic epinephrine receptors of normal and asthmatic individuals.

Authors:  W N Sokol; G N Beall
Journal:  J Allergy Clin Immunol       Date:  1975-05       Impact factor: 10.793

3.  Release of catecholamines in the guinea-pig by substances involved in anaphylaxis.

Authors:  P J Piper; H O Collier
Journal:  Nature       Date:  1967-02-25       Impact factor: 49.962

4.  Pharmacologic control of allergic histamine release in vitro: evidence for an inhibitory role of 3',5'-adenosine monophosphate in human leukocytes.

Authors:  H R Bourne; L M Lichtenstein; K L Melmon
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

5.  Inhibition of the anaphylactic mechanism by sympathomimetic amines.

Authors:  E S Assem; H O Schild
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

6.  The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release.

Authors:  L M Lichtenstein; R DeBernardo
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

7.  Pharmacologic inhibition of the antigen-induced release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE.

Authors:  T Ishizaka; K Ishizaka; R P Orange; K F Austen
Journal:  J Immunol       Date:  1971-05       Impact factor: 5.422

8.  Reactivity of isolated bovine mesenteric and hepatic veins to vasoactive agents and specific antigen.

Authors:  M C Holroyde; P Eyre
Journal:  Eur J Pharmacol       Date:  1975-01       Impact factor: 4.432

9.  Hematological and pathological changes in acute systemic anaphylaxis in calves: effects of pharmacological agents.

Authors:  P W Wells; P Eyre; J H Lumsden
Journal:  Can J Comp Med       Date:  1973-04

10.  Immunological release of histamine and slow reacting substance of anaphylaxis from human lung.

Authors:  M Kaliner; R P Orange; K F Austen
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Auto-modulation of release of pharmacological mediators of immediate (type I) hypersensitivity. A review.

Authors:  M C Holroyde; J F Burka; P Eyre
Journal:  Agents Actions       Date:  1977-10

2.  Association of plasma haptoglobin concentration and other biomarkers with bovine respiratory disease status in pre-weaned dairy calves.

Authors:  Sonia J Moisá; Sharif S Aly; Terry W Lehenbauer; William J Love; Paul V Rossitto; Alison L Van Eenennaam; Sophia C Trombetta; Eduarda M Bortoluzzi; Lindsey E Hulbert
Journal:  J Vet Diagn Invest       Date:  2018-10-17       Impact factor: 1.279

3.  The effect of catecholamines on the in vivo and in vitro responses of the cat lung during anaphylaxis.

Authors:  H W Mitchell; M P Sparrow
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.